Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma
Clinical trial NCT02023333 · COMPLETED
Trial details
- NCT number
- NCT02023333
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-10
- Primary completion
- 2025-08-26
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.